Drug Shortage Report for LEVITRA

Last updated on 2023-07-14 History
Report ID 49555
Drug Identification Number 02250462
Brand name LEVITRA
Common or Proper name Vardenafil tablets
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) VARDENAFIL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4's
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-06-30
Actual start date
Estimated end date Unknown
Actual end date 2020-11-16
Shortage status Resolved
Updated date 2023-07-14
Company comments DIN discontinued as of November 16, 2020.
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-05-16 English Compare
v2 2018-05-16 English Compare
v3 2018-05-16 French Compare
v4 2018-07-01 English Compare
v5 2018-08-29 English Compare
v6 2018-08-29 French Compare
v7 2018-09-21 English Compare
v8 2018-09-21 French Compare
v9 2018-10-12 English Compare
v10 2018-10-12 French Compare
v11 2018-10-12 English Compare
v12 2018-10-12 English Compare
v13 2018-10-12 French Compare
v14 2018-12-03 English Compare
v15 2018-12-03 French Compare
v16 2019-01-25 English Compare
v17 2019-01-25 French Compare
v18 2019-03-29 English Compare
v19 2019-03-29 French Compare
v20 2020-07-31 English Compare

Showing 1 to 20 of 23